Republic Technologies Inc. Announces Up to US$100 Million Proposed Secured Convertible Note Facility Financing
Vancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - Republic Technologies Inc. (CSE: DOCT) (FSE: 7FM0) (WKN: A41AYF) (the "Company" or "Republic") is pleased to announce that it proposes to enter into a financing agreement with an institutional investor (the "Investor") for a proposed secured convertible note facility of up to US$100 million (the "Proposed Convertible Facility") (the "Proposed Financing"), featuring an initial US
Technology, Pharmaceuticals, Health
2025-10-20 9:20 AM EDT | Republic Technologies Inc.
Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner
Burlington, Ontario--(Newsfile Corp. - October 20, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company developing innovative drug delivery solutions through its QuickStrip™ platform, today issued a comprehensive update on its nicotine strategy, including the extension of its exclusive pre-commercialization and development agreement (the "Agreement") with its international nicotine partner. The Agreement,
2025-10-20 8:48 AM EDT | Rapid Dose Therapeutics Corp.
Akanda Corp. Increasing Its Cannabis Investment
Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), through its cannabis operating subsidiary, has furthered its cannabis investment by extending its option on its British Columbia asset for two additional years. The Company has been working on obtaining its full cultivation license for a variety of potential products containing THC, but currently it is operating under its hemp cultivation license. A further extension of the license
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-10-20 8:00 AM EDT | Akanda Corp
Predictmedix AI Announces Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, announces a proposed non brokered private placement. The Company intends to issue (the "Offering") of up to 18,000,000 units (each, a "Unit") at a price of C$0.05 per Unit, for aggregate gross proceeds to the Company of up to C$900,000. Each Unit will be comprised of one c
2025-10-20 7:05 AM EDT | QScreen AI Inc.
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
Vancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its News Releases of September 4, 2025, September 19, 2025 and October 10, 2025, it will be proceeding to complete its previou
Biotechnology, Pharmaceuticals, Health
2025-10-20 7:00 AM EDT | PreveCeutical Medical Inc.
Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study
Halifax, Nova Scotia--(Newsfile Corp. - October 20, 2025) - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce the completion of its first-in-human clinical study treating patients with histologically confirmed, immunotherapy-resistant cutaneous metastatic melanoma using Sona's Targeted Hyperthermia Therapy ("THT"). Ten advanced-stage patients, all of whom were failing to respond to standard immunotherapy treatment, were recruited int
2025-10-20 6:00 AM EDT | Sona Nanotech Inc.
Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardiology conference in November 2025. Next-generation therapy CR
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-10-17 4:34 PM EDT | Cardiol Therapeutics Inc.
Sona Nanotech To Host Investor Webinar To Discuss Clinical Study
Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that it will host a webinar on Monday, October 20th at noon EDT to discuss its first-in-human, early feasibility clinical study for its Targeted Hyperthermia Therapy cancer treatment. Ten advanced stage melanoma patients who were failing to respond to standard immunotherapy treatment were recruited into this early feasibility stu
2025-10-17 4:04 PM EDT | Sona Nanotech Inc.
MyndTec Inc. Completes Sixth Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - October 16, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed the sixth tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering"). The sixth tranche of the private placement consists of 263,428 Units of the Company (the "Units") at a price of $0.20 per Uni
Technology, Healthcare and Hospitals, Health
2025-10-16 6:00 PM EDT | MyndTec Inc.
Akanda To Accelerate Recurring Revenue with Expansion Of Up To 20 New Cellular Towers
Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today a major network expansion initiative with the construction of new cellular towers within the proximity of its existing tower network. The Company plans to construct and/or acquire up to 20 new or existing towers/sites by the end of
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-10-16 4:15 PM EDT | Akanda Corp
El Salvador Emerges as a Prime Investment Destination with Historic Public Safety Gains and Bold Institutional Reforms
San Salvador, El Salvador--(Newsfile Corp. - October 16, 2025) - El Salvador is consolidating its position as a prime investment destination. In 2025, it recorded a remarkable surge in foreign direct investment (FDI) and offered a business environment strengthened by macroeconomic reform, regulatory efficiency, and historic advances in public safety. To build on this momentum, Invest in El Salvador, the country's promotional agency, will lead a U.S. roadshow this month, wi
Auto Manufacturers, Environmental Services, Energy, Health
2025-10-16 3:08 PM EDT | LinkUp Global
Conexeu Sciences Closes Maximum $5M Reg CF Financing
Reno, Nevada--(Newsfile Corp. - October 16, 2025) - Conexeu Sciences Inc. (the "Company" or "Conexeu") a biotechnology company revolutionizing tissue regeneration, is pleased to announce the completion of its $5 million Regulation Crowdfunding (Reg CF) financing. Conexeu secured commitments in excess of $5 million in less than two weeks from the date of launching the financing through the Equifund platform.
Healthcare and Hospitals, Pharmaceuticals, Health
2025-10-16 9:01 AM EDT | Conexeu Sciences Inc.
Mobile-health Network Solutions and Brands For Good Unite to Champion Corporate Wellness and Doing Good
Singapore, Singapore--(Newsfile Corp. - October 16, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced a strategic partnership with Brands For Good Ltd ("BFG"), an organization dedicated to recognizing and empowering companies that do good for their communities. According to the partnership, MNDR will provide BFG member companies and their employees with access to corporate wellnes
2025-10-16 8:30 AM EDT | Mobile-health Network Solutions
Cheelcare Appoints Dave Jones as Director of U.S. Sales
Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian leader in assistive mobility devices, is pleased to announce the appointment of Dave Jones as Director of U.S. Sales, effective immediately. Mr. Jones brings over 30 years of executive sales and marketing experience in the complex rehabilitation and durable medical equipment (DME) sectors. His career includes senior roles at Drive Medical, Merits Healthcare, Qua
2025-10-16 8:00 AM EDT | Cheelcare Inc.
Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol
Calgary, Alberta--(Newsfile Corp. - October 15, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to no-option individuals suffering from angina, peripheral arterial disease, chronic limb threatening ischemia, ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy, congestive heart failure, and total body ischemia, in Florida under Florida's SB 1768, is pleased to annou
Biotechnology, Pharmaceuticals, Health
2025-10-15 3:51 PM EDT | Hemostemix Inc.
TempraMed to Commence Trading on the Canadian Securities Exchange Under Symbol "VIVI", Today, October 15, 2025
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company") is pleased to announce that it has received approval to list its common shares (the "Common Shares") on the Canadian Securities Exchange ("CSE"). Trading is expected to commence on CSE under symbol "VIVI" at the open of markets on October 15, 2025. Further, the board of directors (the "Board") of the Compa
Technology, Biotechnology, Pharmaceuticals, Health
2025-10-15 7:00 AM EDT | TempraMed Technologies Ltd
Hear At Last Launches HOHM Token for Capital Raise on Solana Blockchain - Now Ready to Trade
Miami, Florida--(Newsfile Corp. - October 14, 2025) - Hear At Last (OTCID: HRAL), a trailblazer in innovative housing solutions, is thrilled to announce the successful launch of its cryptocurrency token, HOHM, on the Solana blockchain. The HOHM token is now live and ready to trade, marking a pivotal step in HRAL's mission to revolutionize affordable housing through blockchain technology. The primary goal of the HOHM token is to raise capital for Hear At Last's ambitious housing i
Household / Consumer / Cosmetics, Health
2025-10-14 11:44 AM EDT | Hear AtLast Holdings, Inc
Adia Nutrition Paves Way for Nasdaq and New Investors Through SEC Form 10 Submission
Winter Park, Florida--(Newsfile Corp. - October 14, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is thrilled to announce a major milestone in its growth journey. The Company has engaged an independent public accounting firm and securities counsel to prepare and file its Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC). This filing marks a significant step beyond OTC reporting and positions Adia as a fully reporting public company under the Securities Exchange
Healthcare and Hospitals, Health
2025-10-14 9:00 AM EDT | Adia Nutrition Inc.
Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-10-14 8:34 AM EDT | Red Light Holland Corp.
CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery
Houston, Texas--(Newsfile Corp. - October 13, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) today announced the addition of a patent-pending nanoemulsion formulation to its growing portfolio, developed to support female fertility and reproductive function in women of advanced maternal age (35+). CBIH believes this innovation should expand evidence-based options for patients and partners. As age is a key determinant of reproductive outcomes—and first births
Biotechnology, Pharmaceuticals, Cannabis, Health
2025-10-13 7:00 AM EDT | Cannabis Bioscience International Holdings